Literature DB >> 2197093

Prevalence of antibodies to Chlamydia pneumoniae in a pediatric hospital population in Belgium.

L Van Renterghem1, A M Van den Abeele, G Claeys, J Plum.   

Abstract

To evaluate the prevalence of antibodies to Chlamydia pneumoniae in a pediatric hospital population, 207 patients admitted to the pediatric unit of the hospital during the period January to April 1989 were screened. A microimmunofluorescence test was used to measure both Chlamydia pneumoniae specific total antibody and IgM antibody. Fifty-eight (28%) patients were found to have antibodies to Chlamydia pneumoniae. Only one serum contained specific IgM. Analysis of the age specific prevalence of antibody showed a sudden rise in the 10 to 12 year old age group. Cross-reaction in the test with the other Chlamydia species is discussed. It is concluded that the incidence of primary Chlamydia pneumoniae infection during the study period was low, but that the infection occurs in Belgium with about the same prevalence as in other countries.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2197093     DOI: 10.1007/bf01973742

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  9 in total

1.  Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridization.

Authors:  L A Campbell; C C Kuo; J T Grayston
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

2.  Identification of a new group of Chlamydia psittaci strains called TWAR.

Authors:  C C Kuo; H H Chen; S P Wang; J T Grayston
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

3.  Acute lower-respiratory-tract infection associated with chlamydial TWAR antibody in Filipino children.

Authors:  P Saikku; P Ruutu; M Leinonen; J Panelius; T E Tupasi; J T Grayston
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

4.  Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland.

Authors:  M Kleemola; P Saikku; R Visakorpi; S P Wang; J T Grayston
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

5.  Formalinized Chlamydia trachomatis organisms as antigen in the micro-immunofluorescence test.

Authors:  S P Wang; C C Kuo; J T Grayston
Journal:  J Clin Microbiol       Date:  1979-08       Impact factor: 5.948

Review 6.  Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases.

Authors:  J T Grayston; S P Wang; C C Kuo; L A Campbell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-03       Impact factor: 3.267

7.  An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci.

Authors:  P Saikku; S P Wang; M Kleemola; E Brander; E Rusanen; J T Grayston
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

8.  A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.

Authors:  J T Grayston; C C Kuo; S P Wang; J Altman
Journal:  N Engl J Med       Date:  1986-07-17       Impact factor: 91.245

9.  Countrywide epidemics of Chlamydia pneumoniae, strain TWAR, in Scandinavia, 1981-1983.

Authors:  J T Grayston; C Mordhorst; A L Bruu; S Vene; S P Wang
Journal:  J Infect Dis       Date:  1989-06       Impact factor: 5.226

  9 in total
  6 in total

1.  Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community acquired pneumonia.

Authors:  R Chaudhry; N Nazima; B Dhawan; S K Kabra
Journal:  Indian J Pediatr       Date:  1998 Sep-Oct       Impact factor: 1.967

2.  Age-related interference with Chlamydia pneumoniae microimmunofluorescence serology due to circulating rheumatoid factor.

Authors:  R P Verkooyen; M A Hazenberg; G H Van Haaren; J M Van Den Bosch; R J Snijder; H P Van Helden; H A Verbrugh
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

3.  Transport and storage conditions for cultural recovery of Chlamydia pneumoniae.

Authors:  M Maass; K Dalhoff
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

4.  Prevalence of Chlamydia pneumoniae antibodies in patients with acute respiratory infections in Israel.

Authors:  M Ben-Yaakov; Z Lazarovich; S Beer; A Levin; I Shoham; I Boldur
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

5.  Prevalence of Chlamydia pneumoniae antibodies in Hungary.

Authors:  A Marton; A Károlyi; A Szalka
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

6.  Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections.

Authors:  R P Verkooyen; D Willemse; S C Hiep-van Casteren; S A Joulandan; R J Snijder; J M van den Bosch; H P van Helden; M F Peeters; H A Verbrugh
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.